BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW)

CUSIP: G1125A116

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
5,399,999
Share change
+1,947,637
Total reported value
$4,635,000
Price per share
$0.86
Number of holders
32
Value change
+$1,719,940
Number of buys
18
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP G1125A116?
CUSIP G1125A116 identifies BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) as of Q2 2021

As of 30 Jun 2021, BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,399,999 shares. The largest 10 holders included CITADEL ADVISORS LLC, RAMIUS ADVISORS LLC, Corbin Capital Partners, L.P., Linden Advisors LP, KINGSTOWN CAPITAL MANAGEMENT L.P., MMCAP International Inc. SPC, Atalaya Capital Management LP, Blackstone Inc, Periscope Capital Inc., and DG Capital Management, LLC. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.